image dons

I make a donation

AMUNDSEN

Evolocumab or Normal strategies to reach guidelines LDL objectives in patients with acute myocardial infarction treated by percutaneous coronary intervention

En cours

Colloquium : Pathologies cardiaques de la femme (15 novembre 2022)
Présentations en ligne !!!

logo étude

objectif

A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs. Standard of Care as defined by the guidelines but also constrained by current drug availabilities in the different participating countries.

date de réalisation

2021

nombre de patients

1666

nombre de centres participants

International multicentric trial

type de financement

Private (AMGEN and Fonds de Dotation ACTION)

Référence

EUDRACT : 2021-000573-80

A study conducted by Fonds de Dotation ACTION.
Find out details and results on the dedicated page

AMUNDSEN conducted by Fonds de Dotation ACTION

Autres études

+

AFLOAT

En cours


To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.
+

EDUC-DAI

En cours


Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.
+

AMUNDSEN

En cours


A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....